Christopher King, MD
Case Western Reserve University · Inova Fairfax Medical Campus · University of California, Los Angeles
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Christopher King, MD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 05:51 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT04188301 · Safety and Efficacy of IDA for OnchocerciasisWashington University School of Medicine · completed · Onchocerciasis · principal investigator
- N/ANCT03517462 · Ocular Changes After Ivermectin - (DOLF IVM/Oncho)Washington University School of Medicine · completed · Onchocerciasis · principal investigator
- N/ANCT03177993 · Fiji Integrated Therapy (FIT) - Triple Therapy for Lymphatic Filariasis, Scabies and Soil Transmitted Helminths in FijiWashington University School of Medicine · completed · Lymphatic Filariases, Scabies, Impetigo · principal investigator
- N/ANCT02899936 · Death to Onchocerciasis and Lymphatic Filariasis (DOLF) Triple Drug Therapy for Lymphatic FilariasisWashington University School of Medicine · completed · Lymphatic Filariasis · principal investigator
- Ph2NCT02178566 · Pulmonary Rehab in Chronic Obstructive Pulmonary Disease (COPD): Response to TyvasoInova Health Care Services · terminated · Chronic Obstructive Pulmonary Disease (COPD) · principal investigator
- N/ANCT01059513 · Hypo-fractionated Stereotactic Body Radiotherapy for Localized Prostate CancerJonsson Comprehensive Cancer Center · completed · Prostate Cancer · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 05:51 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. 1 other NIH projects list an investigator with the same name at a different institution and are left out. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
PubMed returned no clinical-trial papers for this author name.